University of Ottawa associate professor Amir Attaran is co-author of a study of how much countries pay for generic drugs. Canada pays double what it should, he says.
A new study shows Canada pays more than double for common generic drugs compared to other developed countries. Generic drugs are drugs manufactured after the initial patent on a drug has expired. In Canada, drug programs are administered at the provincial level.
Ontario health critics have called for a review of the purchasing system for the drugs in the wake of the study, published Tuesday.
“We’ve known for a long time that this needs to be changed, but the political will for change has never been there,” said Ontario NDP health critic France Gélinas. Continue reading
Ontario Health Minister Eric Hoskins says he is “deeply concerned” that legislation doesn’t compel mandatory reporting of medical practitioners who sexually abuse patients.
Just a week after Ontario Health Minister Dr. Eric Hoskins said that legislation which allowed doctors’ sexual miscondut to go unreported didn’t need to change, Hoskins has changed his mind and is now ordering a review of the controversial legislation that gives medical regulatory bodies discretion on whether to alert police when one of their members may have committed a crime.
Other provinces and U. S. States have already moved to close this loophole and require reporting by authorities.
If a Mississauga doctor had been practising in Alberta when he put his mouth or cheek on the breasts of more than 10 female patients, the province’s medical regulator would have had to report it to the minister of justice and the solicitor general. Continue reading
Top Canadian doctors running clinical drug trials failed to report serious side-effects suffered by their human test subjects.
According to the Star, the doctors, some of them esteemed researchers from Canada’s top hospitals and academic institutions, have also routinely broken rules designed to protect participants and botched research of new treatments.
Using U.S. Food and Drug Administration (FDA) records obtained through U.S. freedom of information legislation, the Star found serious problems in the system designed to ensure new drugs are safe and effective. Continue reading